Maya here, with the molecule that quietly solves resveratrol's biggest weakness.
If resveratrol's problem is absorption, pterostilbene is the cousin that addresses it. Found in blueberries, it shares much of resveratrol's structure but carries two methyl groups that make it considerably more bioavailable and longer-lasting in the body. In practice, a smaller dose can do more.
Like resveratrol, pterostilbene engages repair and antioxidant pathways and has been studied for metabolic and cellular-aging markers. The human evidence is still developing, and we'll say so plainly — but the bioavailability advantage is real and well characterised, which is why we find it a more rational choice than high-dose resveratrol for many people.
A few measured notes. Pterostilbene is often paired with NAD+ precursors, since their mechanisms are complementary; it tends to be used at modest daily doses; and, as with the whole polyphenol family, it works best layered onto a diet already rich in colourful plants rather than as a substitute for one. Some research has examined its effect on cholesterol markers, which is one reason dose transparency and clinician input matter.
Our stance is consistent: a smaller, better-absorbed dose, clearly labelled, beats a large dose you can't actually use. That is the whole philosophy of the catalogue in a single molecule.
If you'd like to compare, our pterostilbene and resveratrol options sit side by side with full dosing printed.
This article is educational and not medical advice. Speak with a qualified clinician before adding it to your routine.